表紙
市場調査レポート

世界の一塩基多型(SNP:Single Nucleotide Polymorphism)ジェノタイピング・解析市場の予測

Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 308883
出版日 ページ情報 英文 80 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
世界の一塩基多型(SNP:Single Nucleotide Polymorphism)ジェノタイピング・解析市場の予測 Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018
出版日: 2014年07月23日 ページ情報: 英文 80 Pages
概要

一塩基多型(SNP : Single Nucleotide Polymorphism)ジェノタイピング(遺伝子型判定)とは、さまざまな種のゲノム内におけるSNPの遺伝子変異をスクリーニングし、解析する手法です。SNPとはヒトを含むすべてのすべての種が一般的に持つ多型です。SNPのジェノタイピングおよび解析技術は、何千ものSNPの解析が可能であり、全ゲノムジェノタイピングにおいても可能性を秘めています。2013年から2018年にかけて、世界のSNPジェノタイピング・解析市場は20.65%のCAGRで推移すると予測されています。

当レポートでは、世界のSNP(一塩基多型)ジェノタイピング・解析市場について調査し、世界市場の推移と予測、技術・用途・地域別の動向、市場成長への影響因子の分析、競合環境、主要事業者のプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語

第3章 調査の対象

  • 市場概要
  • 提供製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場環境

  • 市場概要
  • 市場規模・予測
  • ファイブフォース分析

第7章 技術別市場

第8章 用途別市場

第9章 地域別市場

  • 南北アメリカにおけるSNPジェノタイピング・解析市場
    • 市場規模・予測
  • 欧州・中東・アフリカにおけるSNPジェノタイピング・解析市場
    • 市場規模・予測
  • アジア太平洋におけるSNPジェノタイピング・解析市場
    • 市場規模・予測

第10章 購入基準

第11章 市場成長推進因子

第12章 市場成長推進因子とその影響

第13章 市場における課題

第14章 市場成長推進因子および課題の影響

第15章 市場動向

第16章 動向とその影響

第17章 ベンダー環境

  • 競合シナリオ
    • 主なニュース
    • 買収・契約
  • ベンダー分析
  • 他の注目ベンダー

第18章 主要ベンダー分析

  • Affymetrix
  • F. Hoffmann La-Roche
  • Illumina
  • Thermo Fisher Scientific
    • 主要データ
    • 事業概要
    • 事業区分:収益別
    • 製品区分:収益別
    • 売上:地域別
    • 事業戦略
    • 主要情報
    • SWOT分析

第19章 本シリーズのその他のレポート

図表

目次
Product Code: IRTNTR3889

About Single Nucleotide Polymorphism Genotyping and Analysis

Single Nucleotide Polymorphism (SNP) genotyping is the screening and analysis of genetic variations of SNPs in the genome of various species. SNPs are commonly present in all species including humans. SNP genotyping and analysis technology can analyze thousands of SNPs and has the potential for whole-genome genotyping. It is the most common genetic variation that occurs in the genetic makeup. It is an emerging field in life science, which provides an in-depth analysis of SNPs. It is generally used by researchers for genomics study. It has a broad range of applications in several industries such as Pharmaceuticals and Pharmacogenomics, Diagnostics Research, Agriculture Biotechnology, and Breeding and Animal Livestock. There are several technologies which are used for SNP genotyping and analysis such as SNP GeneChips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex, and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight.

TechNavio's analysts forecast the Global SNP Genotyping and Analysis market to grow at a CAGR of 20.65 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global SNP Genotyping and Analysis market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of SNP analysis systems, consumables, and services used in SNP analysis. In addition, predominant technologies used for SNP genotyping and analysis, such as SNP gene chips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight, are considered in the scope of the report.

TechNavio's report, the Global SNP Genotyping and Analysis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global SNP Genotyping and Analysis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Affymetrix Inc.
  • Illumina Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.

Other Prominent Vendors

  • Agilent Technologies Inc.
  • Douglas Scientific Llc.
  • Fluidigm Corp.
  • Luminex Corp.
  • PREMIER Biosoft Intl.
  • Promega Corp.
  • Qiagen N. V.
  • Sequenom Inc.
  • WaferGen Biosystems Inc.

Market Driver

  • Advances in Technology

For a full, detailed list, view our report.

Market Challenge

  • Reimbursement Complications

For a full, detailed list, view our report.

Market Trend

  • Increasing Pharmacogenomics Study

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation

  • 09.1. SNP Genotyping and Analysis Market in the Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. SNP Genotyping and Analysis Market in the EMEA Region
    • 09.2.1. Market Size and Forecast
  • 09.3. SNP Genotyping and Analysis Market in the APAC region
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Acquisitions and Agreements
  • 17.2. Vendor Analysis
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Affymetrix
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation
    • 18.1.4. Business Segmentation by Revenue 2013
    • 18.1.5. Business Segmentation by Revenue 2012 and 2013
    • 18.1.6. Sales by Geography
    • 18.1.7. Business Strategy
    • 18.1.8. Key Information
    • 18.1.9. SWOT Analysis
    • 18.1.10. Strengths
    • 18.1.11. Weaknesses
    • 18.1.12. Opportunities
    • 18.1.13. Threats
  • 18.2. F. Hoffmann La-Roche
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Sales by Geography
    • 18.2.6. Business Strategy
    • 18.2.7. Key Information
    • 18.2.8. SWOT Analysis
    • 18.2.9. Strengths
    • 18.2.10. Weaknesses
    • 18.2.11. Opportunities
    • 18.2.12. Threats
  • 18.3. Illumina
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation
    • 18.3.4. Sales by Geography
    • 18.3.5. Business Strategy
    • 18.3.6. Key Information
    • 18.3.7. SWOT Analysis
    • 18.3.8. Strengths
    • 18.3.9. Weaknesses
    • 18.3.10. Opportunities
    • 18.3.11. Threats
  • 18.4. Thermo Fisher Scientific
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation by Revenue
    • 18.4.4. Product Segmentation by Revenue
    • 18.4.5. Sales by Geography
    • 18.4.6. Business Strategy
    • 18.4.7. Key Information
    • 18.4.8. SWOT Analysis
    • 18.4.9. Strengths
    • 18.4.10. Weaknesses
    • 18.4.11. Opportunities
    • 18.4.12. Threats

19. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global SNP Genotyping and Analysis Market 2013-2018 (US$ million)
  • Exhibit 3: Global SNP Genotyping and Analysis Market Segmentation by Technology
  • Exhibit 4: Global SNP Genotyping and Analysis Market Segmentation by Application
  • Exhibit 5: Global SNP Genotyping and Analysis Market Segmentation by Application 2013
  • Exhibit 6: Global SNP Genotyping and Analysis Market by Geographical Segmentation 2013
  • Exhibit 7: SNP Genotyping and Analysis Market in the Americas 2013-2018 (US$ million)
  • Exhibit 8: SNP Genotyping and Analysis Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 9: SNP Genotyping and Analysis Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 10: Global SNP Genotyping and Analysis Market by Geographical Segmentation 2013-2018 (US$ million)
  • Exhibit 11: Global SNP Genotyping and Analysis Market by Geographical Segmentation 2013-2018
  • Exhibit 12: Affymetrix: Business Segmentation 2013
  • Exhibit 13: Affymetrix: Business Segmentation by Revenue 2013
  • Exhibit 14: Affymetrix: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 15: Affymetrix: Sales by Geography 2013
  • Exhibit 16: F. Hoffmann-La Roche: Business Segmentation 2013
  • Exhibit 17: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 18: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
  • Exhibit 19: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
  • Exhibit 20: Illumina: Business Segmentation 2013
  • Exhibit 21: Illumina: Sales by Geography 2013
  • Exhibit 22: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
  • Exhibit 23: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
  • Exhibit 24: Thermo Fisher Scientific: Sales by Geography 2013
Back to Top